Intrinsiqs

Is Chemed Corporation overvalued?

Chemed Corporation (CHE) looks overvalued — trading about 32% above its fair value.

Overvalued
Current price $543.09 Fair value $366.90
Price
$543.09
Fair value
$366.90
Current P/E
25.1
Normal P/E
17.0
Market cap
$7.10B
Dividend yield
0.4%
Return on equity
29.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CHE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.